A carregar...

Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.

Current treatments for brain cancer have, for the most part, equivocal survival benefit. However, clinical trials of new anticancer agents do not adequately assess potential clinical benefits for patient function other than survival and time to tumor progression.We evaluated 56 patients with recurre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meyers, Christina A., Hess, Kenneth R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2003
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1920671/
https://ncbi.nlm.nih.gov/pubmed/12672280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1522-8517-02-00026-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!